Journal Finder

We are interested in the best research from across the field of microbiology, with our broad scope ensuring that the work published reaches the widest possible audience.

Immunology is a diverse and growing discipline that can be defined as the study of the tissues, cells and molecules involved in host defence mechanisms. Immunologists attempt to understand how the immune system develops, how the body defends itself against disease, and what happens when it all goes wrong. Nature Reviews Immunology will provide in-depth coverage of immunology, from fundamental mechanisms to applied aspects. In addition to review articles, it will highlight recent developments and exciting new primary papers, as well as reflecting on the people, papers and events that have influenced the development of immunology.Subjects covered * Allergy and asthma * Autoimmunity * Antigen processing and presentation * Apoptosis in the immune system * Chemokines and chemokine receptors * Cytokines and cytokine receptors * Development and function of cells of the immune system * Development and function of cells of the immune system * Haematopoiesis * Infection and immunity * Immunotherapy * Innate immunity * Mucosal immunology * Regulation of the immune response * Signalling in the immune system * Transplantation * Development and function of cells of the immune system * Tumour immunology * Vaccine development.

The advent of new technologies and growing recognition of the enormous degree of microbial diversity has revolutionized our understanding of microbiology as a discipline. Microbiology is moving into a new era that focuses less on specific organisms and more on the processes and mechanisms that link them. Nature Reviews Microbiology embraces this new era by encompassing the discipline in its broadest sense. We take an integrated approach to microbiology, bridging fundamental research and its clinical, industrial and environmental applications to create a single information resource for all who share an interest in microbial life. Nature Reviews Microbiology publishes the highest-quality reviews and perspectives highlighting important developments in our understanding of bacteria, archaea, viruses, fungi and protozoa, their interaction with their environments, how these organisms are harnessed in human endeavour and their impact on society. Also featured are timely summaries of significant research papers, as well as monthly updates on the latest developments in microbial genomics, post-genomic biology and infectious diseases. In line with our ongoing ambition to overcome the traditional barriers between bacteriology, virology, mycology and archaeal and protozoan biology, articles are tailored to appeal to microbiologists of every persuasion and at every level. The scope of the journal encompasses, but will not be limited to, the following fields pertaining to bacteria, archaea, viruses, fungi and protozoa: * Biochemistry, physiology and molecular biology * Genetics and genomics * Ecology, evolution and biodiversity * Cellular microbiology * Environmental microbiology * Pathogenesis and host defence * Clinical and diagnostic microbiology * Infectious diseases * Antimicrobial therapies and vaccines * Epidemiology and public health microbiology * Applied and industrial microbiology * Microbiology education * Microbiology and society.

The rapidly expanding field of neuroimmunomodulation explores the way in which the nervous system interacts with the immune system via neural, hormonal, and paracrine actions. Encompassing both basic and clinical research, Neuroimmunomodulation reports on all aspects of these interactions. Basic investigations consider all neural and humoral networks from molecular genetics through cell regulation to integrative systems of the body. The journal welcomes reports on the basic mechanisms involved in the CNS pathology of various neurodegenerative diseases. Although primarily devoted to research articles, timely reviews are published on a regular basis.

New Microbes and New Infections is an official publication of the https://www.escmid.org/European Society of Clinical Microbiology and Infectious Diseases (ESCMID). It serves the field as a peer-reviewed, open access journal for rapid dissemination of the latest research, with a particular focus on new genomes, new microbes, and new technology applied to the diagnosis of infectious/tropical diseases. Article categories include first descriptions of a microbe in a country, first descriptions of resistance in a country, first case reports in a country and mini-reviews, as well as full length original articles. New Microbes and New Infections offers clinicians and researchers a rapid route to publication and the opportunity to publish in a highly visible global forum. The journal draws on the same expert panel of reviewers as http://www.journals.elsevier.com/clinical-microbiology-and-infection/Clinical Microbiology and Infection (CMI). This new journal’s emphasis on concise reports on specific topics distinguishes it from Clinical Microbiology and Infection, which will continue to publish manuscripts presenting basic and applied research in the fields of microbiology, infectious diseases, virology, parasitology, immunology and epidemiology. The open access format of New Microbes and New Infections ensures that accepted manuscripts will be rapidly published and fully accessible by interested professionals worldwide.

OncoImmunology will accept high-profile submissions in the fundamental, translational and clinical areas of tumor immunology. Submissions dealing with solid or hematological cancers, inflammation, innate and acquired immune responses will be welcome.

Open Biology is a fast, open access journal covering biology at the molecular and cellular level. Open Biology publishes original, high quality research in cell biology, developmental and structural biology, molecular biology, biochemistry, neuroscience, immunology, microbiology and genetics.

PLoS Biology features works of exceptional significance, originality, and relevance in all areas of biological science, from molecules to ecosystems, including works at the interface of other disciplines, such as chemistry, medicine, and mathematics. Our audience is the international scientific community as well as educators, policy makers, patient advocacy groups, and interested members of the public around the world.

Bacteria, fungi, parasites, prions and viruses cause a plethora of diseases that have important medical, agricultural, and economic consequences. Moreover, the study of microbes continues to provide novel insights into such fundamental processes as the molecular basis of cellular and organismal function. PLoS Pathogens reflects the full breadth of research in these areas by publishing outstanding original articles that significantly advance the understanding of pathogens and how they interact with their host organisms. Topics include (but are not limited to) adaptive and innate immune defenses as well as pathogen countermeasures, emerging pathogens, evolution, genomics and gene regulation, model host organisms, pathogen-cell biology, pathogenesis, prions, proteomics and signal transduction, rational vaccine design, structural biology, and virulence factors.PLoS Pathogens will consider studies that provide fundamental new understanding of the pathogen or pathogenic mechanisms. The journal will not consider purely descriptive studies, such as those that solely identify a new genomic sequence of a related pathogen or a series of related pathogens, the isolation of pathogen variants, or a new strain or type based only on sequence analysis. Such studies, as well as correlative studies of host and pathogen genotypes, would be considered if they use further experiments to test an idea or validate a mechanistic model, or to provide a clear set of novel conclusions that derive from the data.

Help with achieving parasitology progress and, especially, favour every kind of scientific exchange among researchers to promote a comparative parasitology.Members.

There is an increasing amount of research in the parasitology area that analyses the patterns, causes, and effects of health and disease conditions in defined populations. This epidemiology of parasite infectious diseases is predominantly studied in human populations but also spans other major hosts of parasitic infections and as such this journal will have a broad remit. We will focus on the major areas of epidemiological study including disease etiology, disease surveillance, drug resistance and geographical spread and screening, biomonitoring, and comparisons of treatment effects in clinical trials for both human and other animals. We will also look at the epidemiology and control of vector insects.

The journal will also cover the use of geographic information systems (Epi-GIS) for epidemiological surveillance which is a rapidly growing area of research in infectious diseases. Molecular epidemiological approaches are also particularly encouraged.

Parasite Immunology is an international journal devoted to research on all aspects of parasite immunology in human and animal hosts. Emphasis has been placed on how hosts control parasites, and the immunopathological reactions which take place in the course of parasitic infections. The Journal welcomes original work on all parasites, particularly human parasitology, helminths, protozoa and ectoparasites.

Parasites & Vectors is an open access, peer-reviewed online journal dealing with the biology of parasites, parasitic diseases, intermediate hosts, vectors and vector-borne pathogens. Manuscripts published in this journal will be available to all worldwide, with no barriers to access, immediately following acceptance. However, authors retain the copyright of their material and may use it, or distribute it, as they wish.

Manuscripts on all aspects of the basic and applied biology of parasites, intermediate hosts, vectors and vector-borne pathogens will be considered. In addition to the traditional and well-established areas of science in these fields, we also aim to provide a vehicle for publication of the rapidly developing resources and technology in parasite, intermediate host and vector genomics and their impacts on biological research. We are able to publish large datasets and extensive results, frequently associated with genomic and post-genomic technologies, which are not readily accommodated in traditional journals. Manuscripts addressing broader issues, for example economics, social sciences and global climate change in relation to parasites, vectors and disease control, are also welcomed.

The electronic format of the journal offers interesting opportunities for authors. For example, in addition to the publication of large datasets, derived from field and laboratory studies, there is no limit to the number of color illustrations that can be included. Animations, slide shows and movie clips are acceptable, as also are links to relevant material on other websites. No additional charge will be made for these.

Parasitology International provides a medium for rapid, carefully reviewed publications in the field of human and animal parasitology. Original papers, rapid communications, and original case reports from all geographical areas and covering all parasitological disciplines, including structure, immunology, cell biology, biochemistry, molecular biology, and systematics, may be submitted. Reviews on recent developments are invited regularly, but suggestions in this respect are welcome. Letters to the Editor commenting on any aspect of the Journal are also welcome.Most downloaded papersBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com